Free Trial

Q3 2024 EPS Estimates for Teladoc Health, Inc. (NYSE:TDOC) Lowered by Leerink Partnrs

Teladoc Health logo with Medical background

Teladoc Health, Inc. (NYSE:TDOC - Free Report) - Equities research analysts at Leerink Partnrs lowered their Q3 2024 earnings per share estimates for Teladoc Health in a report released on Sunday, June 16th. Leerink Partnrs analyst M. Cherny now anticipates that the health services provider will earn ($0.17) per share for the quarter, down from their prior estimate of ($0.15). Leerink Partnrs has a "Market Perform" rating on the stock. The consensus estimate for Teladoc Health's current full-year earnings is ($1.05) per share. Leerink Partnrs also issued estimates for Teladoc Health's Q4 2024 earnings at ($0.05) EPS, FY2024 earnings at ($1.07) EPS, FY2025 earnings at ($0.82) EPS, FY2026 earnings at ($0.63) EPS and FY2027 earnings at ($0.46) EPS.

A number of other equities research analysts have also recently issued reports on the stock. Royal Bank of Canada dropped their target price on shares of Teladoc Health from $25.00 to $18.00 and set an "outperform" rating for the company in a research report on Friday, April 26th. Barclays dropped their target price on shares of Teladoc Health from $25.00 to $20.00 and set an "overweight" rating for the company in a research report on Friday, April 26th. Stifel Nicolaus dropped their target price on shares of Teladoc Health from $21.00 to $16.00 and set a "hold" rating for the company in a research report on Friday, April 26th. Canaccord Genuity Group dropped their target price on shares of Teladoc Health from $28.00 to $25.00 and set a "buy" rating for the company in a research report on Friday, April 26th. Finally, TD Cowen lowered their price objective on shares of Teladoc Health from $16.00 to $15.00 and set a "hold" rating for the company in a research report on Friday, April 26th. Thirteen analysts have rated the stock with a hold rating and six have assigned a buy rating to the company's stock. According to MarketBeat.com, Teladoc Health presently has a consensus rating of "Hold" and an average price target of $18.22.


Check Out Our Latest Report on TDOC

Teladoc Health Price Performance

Shares of NYSE:TDOC traded down $0.02 during midday trading on Wednesday, reaching $10.09. 5,038,706 shares of the company's stock were exchanged, compared to its average volume of 4,033,264. The company's 50 day simple moving average is $12.08 and its two-hundred day simple moving average is $16.19. The firm has a market capitalization of $1.71 billion, a PE ratio of -7.16 and a beta of 0.99. Teladoc Health has a 12 month low of $9.72 and a 12 month high of $30.41. The company has a debt-to-equity ratio of 0.67, a quick ratio of 3.74 and a current ratio of 3.82.

Teladoc Health (NYSE:TDOC - Get Free Report) last issued its quarterly earnings results on Thursday, April 25th. The health services provider reported ($0.49) earnings per share for the quarter, missing analysts' consensus estimates of ($0.47) by ($0.02). Teladoc Health had a negative net margin of 8.90% and a negative return on equity of 10.13%. The company had revenue of $646.13 million during the quarter, compared to the consensus estimate of $637.31 million. During the same period last year, the company earned ($0.37) earnings per share. Teladoc Health's revenue for the quarter was up 2.7% on a year-over-year basis.

Insider Buying and Selling at Teladoc Health

In other news, insider Laizer Kornwasser sold 10,411 shares of the business's stock in a transaction dated Thursday, May 2nd. The shares were sold at an average price of $12.69, for a total value of $132,115.59. Following the completion of the sale, the insider now owns 86,070 shares of the company's stock, valued at $1,092,228.30. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. In related news, insider Arnnon Geshuri sold 7,500 shares of the company's stock in a transaction dated Monday, March 25th. The shares were sold at an average price of $15.06, for a total transaction of $112,950.00. Following the completion of the sale, the insider now owns 38,470 shares of the company's stock, valued at $579,358.20. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Laizer Kornwasser sold 10,411 shares of the company's stock in a transaction dated Thursday, May 2nd. The stock was sold at an average price of $12.69, for a total transaction of $132,115.59. Following the sale, the insider now directly owns 86,070 shares of the company's stock, valued at approximately $1,092,228.30. The disclosure for this sale can be found here. Insiders have sold a total of 39,650 shares of company stock worth $505,863 over the last ninety days. Insiders own 0.95% of the company's stock.

Institutional Investors Weigh In On Teladoc Health

Several institutional investors and hedge funds have recently bought and sold shares of TDOC. ICA Group Wealth Management LLC bought a new position in shares of Teladoc Health in the fourth quarter worth about $28,000. Hexagon Capital Partners LLC lifted its holdings in shares of Teladoc Health by 204.4% in the fourth quarter. Hexagon Capital Partners LLC now owns 1,586 shares of the health services provider's stock worth $34,000 after acquiring an additional 1,065 shares during the last quarter. RIA Advisory Group LLC bought a new position in shares of Teladoc Health in the fourth quarter worth about $36,000. GAMMA Investing LLC bought a new position in shares of Teladoc Health in the fourth quarter worth about $41,000. Finally, Principal Securities Inc. bought a new position in shares of Teladoc Health in the fourth quarter worth about $45,000. Institutional investors own 76.82% of the company's stock.

Teladoc Health Company Profile

(Get Free Report)

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.

Read More

Earnings History and Estimates for Teladoc Health (NYSE:TDOC)

Should you invest $1,000 in Teladoc Health right now?

Before you consider Teladoc Health, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Teladoc Health wasn't on the list.

While Teladoc Health currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Buy And Hold Forever Cover

Click the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

3 Strong Buy Stocks for a Summer Surge

3 Strong Buy Stocks for a Summer Surge

In this video, we break down the factors driving the market's impressive performance and why the S&P could rise another 15% by year's end.

Related Videos

7 Cheap Dividend Stocks Offering Value and Price Upside

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines